facebook twitter linkedin
  • images/stories/slider.png
  • images/stories/slider2.png
  • images/stories/slider3.png
  • images/stories/slider4.png

NEWS RELEASES

  • Selvita presents at the 16th Annual Drug Discovery Leaders’ Summit

    Krakow, 27 May 2015 – Selvita is a proud sponsor of the upcoming 16th Annual Drug Discovery Leaders’ Summit, which will take place 8 - 9 June in Berlin, Germany. &nbs is summit brings together a host of senior level experts to discuss recent develop…

    Read More...

  • Selvita shows strong revenue growth in the first quarter of 2015

    Krakow, 12 May 2015 - Selvita, the largest drug discovery company in Central and Eastern Europe, generated a net profit of PLN 1.3 MM in the first quarter of 2015, which marks 119% increase as compared to Q1 2014. EBITDA reached value of PLN 1.9 MM,…

    Read More...

  • Selvita initiates IND-enabling Studies for its first-in-class PIM/FLT3 inhibitor

    Krakow, 31 March 2015 - Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, announced today that it is commencing IND-enabling studies for SEL24 project, the company’s first oncology drug candidate. &n SEL24 is a nov…

    Read More...